Compare

Natural Alternatives International Inc vs Niagen Bioscience, Inc. vs Marimed Inc. vs Glass House Brands Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearNatural Alternatives International Inc
NAII
Niagen Bioscience, Inc.
NAGE
Marimed Inc.
MRMD
Glass House Brands Inc.
GLAS
Year ended2026-06-302025-12-312025-12-312025-12-31
Revenue$142.51M$129.42M$159.83M$181.98M
Revenue growth (YoY)+9.7%+29.9%+1.3%-9.4%
Gross margin6.3%64.3%36.2%42.3%
Operating margin-13.2%12.6%-1.8%-9.1%
Net margin-14.5%13.4%-9.1%-16.3%
Net income-$20.70M$17.38M-$14.48M-$29.66M
EPS (Diluted)-$3.43$0.20-$0.04-$0.55
Operating cash flow-$8.92M$13.50M$7.70M$11.45M
Free cash flow-$12.62Mn/a$6.53M-$15.73M
Cash & equivalents$7.39Mn/an/an/a
Total assets$126.45M$106.41M$202.56M$318.56M
Total liabilities$76.49M$29.87M$137.83M$143.96M
Shareholders' equity$49.96M$76.53M$50.01M$73.94M
Return on year-end equity-41.4%22.7%-29.0%-40.1%
Shares outstanding6.27M79.71M396.91Mn/a

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearNatural Alternatives International IncNiagen Bioscience, Inc.Marimed Inc.Glass House Brands Inc.
Latest$142.51M
Ended 2026-06-30
$129.42M
Ended 2025-12-31
$159.83M
Ended 2025-12-31
$181.98M
Ended 2025-12-31
1 year earlier$129.86M
Ended 2025-06-30
$99.60M
Ended 2024-12-31
$157.71M
Ended 2024-12-31
$200.90M
Ended 2024-12-31
2 years earlier$113.80M
Ended 2024-06-30
$83.57M
Ended 2023-12-31
$148.60M
Ended 2023-12-31
$160.84M
Ended 2023-12-31
3 years earlier$154.01M
Ended 2023-06-30
$72.05M
Ended 2022-12-31
$134.01M
Ended 2022-12-31
$84.87M
Ended 2022-12-31
4 years earlier$170.97M
Ended 2022-06-30
$67.45M
Ended 2021-12-31
$121.46M
Ended 2021-12-31
$63.19M
Ended 2021-12-31